SBRT for Ventricular Arrhythmia - Trial NCT06411392
Access comprehensive clinical trial information for NCT06411392 through Pure Global AI's free database. This phase not specified trial is sponsored by Medical University of Graz and is currently Recruiting. The study focuses on Ventricular Arrythmia. Target enrollment is 10 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Medical University of Graz
Timeline & Enrollment
N/A
Mar 01, 2024
Feb 01, 2027
Primary Outcome
Safety of treatment,Efficacy of treatment
Summary
The aim of this study is to demonstrate the safety and efficacy of STAR (Stereotactic
 Antiarrhythmic Radiotherapy) in patients with VT (ventricular tachycardia) who are
 unresponsive to standard treatments. Additionally, the planned study aims to provide further
 insights into the effects of STAR on VT burden, ICD interventions, and insights regarding
 late toxicities, particularly those related to the heart, which are currently not well
 understood.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06411392
Non-Device Trial